Jun 25, 2026
17 MIN READ

What to Expect When Starting Wegovy: A Guide to Your First Weeks and Beyond

Beginning semaglutide therapy involves a gradual dose escalation designed to minimize nausea while your body adapts to GLP-1 signaling. Understanding the first-month timeline helps you stay committed to your weight loss journey.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 25, 2026
17 MIN READ

what to expect when starting wegovy: a guide to your first weeks and beyond — PlexusDx GLP-1 education

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection activates GLP-1 receptors in your brain and gut, reducing hunger signals and slowing stomach emptying. Most patients begin at a starting dose of 0.25 mg weekly, with increases every four weeks to reach an effective therapeutic level. Knowing what to expect during this adjustment period builds confidence and helps you recognize normal adaptation responses.

Week One Through Four: The Starting Dose Phase

Your first semaglutide injection marks the beginning of a carefully controlled titration schedule. The initial 0.25 mg dose is intentionally low to allow your gastrointestinal system and appetite-regulation pathways to acclimate gradually. During this period, many patients notice subtle appetite reduction, a slight decrease in food cravings, or mild changes in how certain foods taste. Some people experience minimal side effects in week one, while others report mild nausea or stomach discomfort that typically resolves within a few days as your body adjusts.

By the end of week four, your next dose increase is scheduled. At this point, you should assess your hunger levels, any side effects you experienced, and whether you're eating less without forcing yourself to restrict. PlexusDx recommends keeping a brief food and symptom log during this window so you can report accurate baseline data at your consultation. This information helps your provider determine whether you're ready for the standard four-week progression or whether you benefit from an extended timeline at your current dose.

Weeks Five Through Eight: The First Dose Escalation

At your four-week mark, your semaglutide dose typically increases to 0.5 mg—double your starting amount. This step often produces more noticeable appetite suppression and weight loss acceleration. Many patients report fuller feelings after smaller meals, reduced hunger between meals, and diminished interest in high-calorie or processed foods. Nausea becomes more common at this stage in some individuals, though it typically peaks within the first 2–3 days after the dose increase and subsides as your body adapts.

This is the window where mindful eating becomes critical. Semaglutide works best when paired with intentional meal choices—you'll naturally eat less, but the medication doesn't force healthy food preferences. Protein intake, adequate hydration, and regular movement all amplify the weight loss response. If you experience significant nausea or gastrointestinal distress beyond mild queasiness, contact your PlexusDx provider; they can adjust your timeline or recommend supportive strategies without interrupting your treatment.

Months Two and Three: Finding Your Therapeutic Level

Between weeks nine and twelve, most patients reach either their maintenance dose or continue escalating toward it. The standard therapeutic range for weight loss sits between 1.0 and 2.4 mg weekly. During this phase, your appetite suppression stabilizes and side effects often diminish as your system fully acclimates. Weight loss velocity typically increases as your dose reaches therapeutic levels—clinical trials show average losses of 5–10 pounds per month once the body responds fully to the medication.

Your PlexusDx provider tracks your progress through check-ins and adjusted protocols based on your reported outcomes. Some patients plateau or experience diminishing appetite suppression at certain doses; others reach optimal response at lower doses than others. This individual variation is where the Precision Peptide Genetic Test becomes valuable. By analyzing your genetic predispositions in key pathways—including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609—PlexusDx can predict whether you may respond optimally at standard doses or might benefit from alternative compounds like tirzepatide or dual-compound options.

Managing Side Effects and Staying Committed

Nausea remains the most common side effect, affecting 25–50% of users across the first two months. It's usually mild to moderate, but severity varies widely based on genetics, food choices, and individual tolerance. Eating smaller, protein-rich meals; avoiding high-fat or greasy foods; and staying hydrated can reduce nausea significantly. Some patients find ginger supplements, slow eating paces, or timing meals strategically around their weekly injection helpful. These approaches address symptoms without interrupting your treatment course.

Other potential early-stage effects include mild constipation, slight fatigue, or temporary changes in taste. These typically resolve within 2–4 weeks as your digestive system adjusts. Importantly, semaglutide does not cause nutrient deficiencies in the short term, but taking a daily multivitamin during weight loss supports your metabolic health. If side effects persist beyond the expected adaptation window or feel unmanageable, PlexusDx providers can discuss dose timing adjustments, dietary modifications, or—if necessary—exploring alternative GLP-1 agents that may suit your physiology better.

Building Sustainable Habits Beyond the First Three Months

Once you've navigated the first quarter on semaglutide, your medication becomes part of your baseline. The intense appetite reduction that felt dramatic in weeks 1–4 becomes your new normal, and you begin recognizing hunger as physiological fuel need rather than emotional desire. This mental shift, combined with the medication's neurological effects, makes calorie restriction feel easier and less psychologically taxing than traditional dieting. Many patients report feeling less food-obsessed and sleeping better due to improved metabolic regulation.

This is the optimal time to establish exercise routines, food preparation habits, and stress management practices that will support lasting results after you eventually stop semaglutide therapy. Research shows that combined medication plus lifestyle modification produces superior long-term weight maintenance compared to either approach alone. PlexusDx supports this integration through ongoing provider consultations and personalized guidance. Your dose may continue increasing if your provider determines higher levels align with your goals and tolerance, but your price remains fixed—PlexusDx's commitment ensures your dose escalation never triggers cost increases.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I feel hungry at all once semaglutide kicks in?

No—semaglutide dramatically blunts appetite, but you won't feel starved. Most patients report normal hunger returning if they skip meals, signaling true physiological need. The medication eliminates the constant food preoccupation and cravings many experience before treatment, allowing you to eat for energy rather than emotion.

How much weight should I expect to lose in the first month?

Initial weight loss in month one averages 2–4 pounds, mostly water weight as your calorie intake drops. By month three, as your dose reaches therapeutic levels, many patients lose 5–10 pounds monthly. Individual results vary based on starting weight, genetics, and lifestyle factors; your PlexusDx provider can set realistic expectations during your first consultation.

Why does PlexusDx offer compounded semaglutide starting at $149 per month?

PlexusDx partners with licensed 503A compounding pharmacies to provide pharmaceutical-grade semaglutide at lower cost than brand medications, with no insurance required and HSA/FSA eligibility. Your dose may increase over time, but your price stays flat—ensuring affordability throughout your treatment journey.

Is nausea during the first weeks normal, and when should I worry?

Mild nausea during weeks 1–3 is expected as your GLP-1 pathways activate; it typically resolves within days of each adjustment. However, severe nausea preventing food or fluid intake warrants immediate contact with your PlexusDx provider. They can discuss supportive strategies, dietary changes, or alternative timing that keeps you safe and on track.

How does the Precision Peptide Genetic Test help in my first weeks?

The test analyzes your genetics across 14 peptide pathways, including GLP1R and GIPR variants, to predict whether standard semaglutide dosing will optimize your response or whether you might benefit from tirzepatide or combination therapies. Taking it after your first month of treatment lets PlexusDx refine your protocol for maximum efficacy at your lowest effective dose.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves